Zenodo
What are the clinical outcomes of using sequential treatment with teriparatide followed by romosozumab for osteoporosis in postmenopausal women?
By Tripdatabase.
Abstract
The sequential treatment of teriparatide followed by romosozumab is recommended for postmenopausal women with osteoporosis at high fracture risk, showing improvements in bone mineral density and fracture reduction. However, prior treatment history may affect the efficacy of this sequence, warranting careful patient-specific assessment.
Keywords
- Bone health and osteoporosis research
- teriparatide
- romosozumab
- sequential therapy
- osteoporosis
- postmenopausal women